These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30028898)

  • 1. The use of memantine in neuropsychiatric disorders: An overview.
    Lu S; Nasrallah HA
    Ann Clin Psychiatry; 2018 Aug; 30(3):234-248. PubMed ID: 30028898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
    Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
    BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
    Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
    Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine augmentation for refractory obsessive-compulsive disorder.
    Pasquini M; Biondi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1173-5. PubMed ID: 16730870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.
    Sani G; Serra G; Kotzalidis GD; Romano S; Tamorri SM; Manfredi G; Caloro M; Telesforo CL; Caltagirone SS; Panaccione I; Simonetti A; Demontis F; Serra G; Girardi P
    CNS Drugs; 2012 Aug; 26(8):663-90. PubMed ID: 22784018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
    Aboujaoude E; Barry JJ; Gamel N
    J Clin Psychopharmacol; 2009 Feb; 29(1):51-5. PubMed ID: 19142108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.
    Stewart SE; Jenike EA; Hezel DM; Stack DE; Dodman NH; Shuster L; Jenike MA
    J Clin Psychopharmacol; 2010 Feb; 30(1):34-9. PubMed ID: 20075645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).
    Haghighi M; Jahangard L; Mohammad-Beigi H; Bajoghli H; Hafezian H; Rahimi A; Afshar H; Holsboer-Trachsler E; Brand S
    Psychopharmacology (Berl); 2013 Aug; 228(4):633-40. PubMed ID: 23525525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of off-label uses of memantine for psychiatric disorders.
    Zdanys K; Tampi RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1362-74. PubMed ID: 18262702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
    Feusner JD; Kerwin L; Saxena S; Bystritsky A
    Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation With Memantine in Obsessive-Compulsive Disorder.
    Andrade C
    J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials.
    Zheng W; Zhu XM; Zhang QE; Cai DB; Yang XH; Zhou YL; Ungvari GS; Ng CH; He SH; Peng XJ; Ning YP; Xiang YT
    Schizophr Res; 2019 Jul; 209():12-21. PubMed ID: 31164254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine: a review of possible uses in child and adolescent psychiatry.
    Hosenbocus S; Chahal R
    J Can Acad Child Adolesc Psychiatry; 2013 May; 22(2):166-71. PubMed ID: 23667364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment.
    Hirschtritt ME; Bloch MH; Mathews CA
    JAMA; 2017 Apr; 317(13):1358-1367. PubMed ID: 28384832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine Augmentation Improves Symptoms in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized Controlled Trial.
    Modarresi A; Sayyah M; Razooghi S; Eslami K; Javadi M; Kouti L
    Pharmacopsychiatry; 2018 Nov; 51(6):263-269. PubMed ID: 29100251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Juva K; Alho H
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Indications of Memantine in Psychiatry-Science or Art?
    Aljuwaiser M; Alayadhi N; Ozidu V; Shafik Zakhari SA; Rushdy R; Naguy A
    Psychopharmacol Bull; 2023 Feb; 53(1):30-38. PubMed ID: 36873917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder.
    Modarresi A; Chaibakhsh S; Koulaeinejad N; Koupaei SR
    Psychiatry Res; 2019 Dec; 282():112602. PubMed ID: 31630042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.
    Muhonen LH; Lahti J; Sinclair D; Lönnqvist J; Alho H
    Subst Abuse Treat Prev Policy; 2008 Oct; 3():20. PubMed ID: 18834506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.